Cargando…
The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability
PURPOSE: The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI) is a method for assessing the likelihood that a patient’s muscle symptoms (e.g., myalgia or myopathy) were caused or worsened by statin use. The objectives of this study were to prepare the SAMS-CI for clinical use, estimate its...
Autores principales: | Rosenson, Robert S, Miller, Kate, Bayliss, Martha, Sanchez, Robert J, Baccara-Dinet, Marie T, Chibedi-De-Roche, Daniela, Taylor, Beth, Khan, Irfan, Manvelian, Garen, White, Michelle, Jacobson, Terry A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427100/ https://www.ncbi.nlm.nih.gov/pubmed/28421332 http://dx.doi.org/10.1007/s10557-017-6723-4 |
Ejemplares similares
-
Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study
por: Langslet, Gisle, et al.
Publicado: (2020) -
Statin non-adherence: clinical consequences and proposed solutions
por: Rosenson, Robert S.
Publicado: (2016) -
Inter-rater Agreement for the Clinical Dysphagia Scale
por: Chun, Se Woong, et al.
Publicado: (2011) -
Efficacy and Safety of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia: Phase 3, Multinational Open-Label Study
por: Bruckert, Eric, et al.
Publicado: (2022) -
Clinical inter‐rater reliability of postural control techniques
por: Yuasa, Ken, et al.
Publicado: (2016)